{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:42Z","timestamp":1792081542770,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1124\/jpet.105.095109","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T04:48:32Z","timestamp":1137646112000},"page":"892-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["High-Efficacy 5-Hydroxytryptamine 1A Receptor Activation Counteracts Opioid Hyperallodynia and Affective Conditioning"],"prefix":"10.1016","volume":"316","author":[{"given":"Francis C.","family":"Colpaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Deseure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Stinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Adriaensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.095109_bib1","doi-asserted-by":"crossref","unstructured":"Becerra L, Breiter HC, Wise R, Gonzalez G, and Borsook D (2001) Reward circuitry activation by noxious thermal stimuli. Neuron 32: 927-946.","DOI":"10.1016\/S0896-6273(01)00533-5"},{"key":"10.1124\/jpet.105.095109_bib2","doi-asserted-by":"crossref","unstructured":"Berke JD and Hyman SE (2000) Addiction, dopamine and the molecular mechanisms of memory. Neuron 25: 515-532.","DOI":"10.1016\/S0896-6273(00)81056-9"},{"key":"10.1124\/jpet.105.095109_bib3","doi-asserted-by":"crossref","unstructured":"Bruins Slot LA and Colpaert FC (1999a) Experimental realization of a signal transduction algorithm. J Theor Biol 200: 39-48.","DOI":"10.1006\/jtbi.1999.0973"},{"key":"10.1124\/jpet.105.095109_bib4","doi-asserted-by":"crossref","unstructured":"Bruins Slot LA and Colpaert FC (1999b) Opiate states of memory: receptor mechanisms. J Neurosci 19: 10520-10529.","DOI":"10.1523\/JNEUROSCI.19-23-10520.1999"},{"key":"10.1124\/jpet.105.095109_bib5","doi-asserted-by":"crossref","unstructured":"Bruins Slot LA and Colpaert FC (1999c) Recall rendered dependent on an opiate state. Behav Neurosci 113: 337-344.","DOI":"10.1037\/\/0735-7044.113.2.337"},{"key":"10.1124\/jpet.105.095109_bib6","doi-asserted-by":"crossref","unstructured":"Bruins Slot LA and Colpaert FC (2003) A persistent, opioid-addiction state of memory. Behav Pharmacol 14: 167-171.","DOI":"10.1097\/00008877-200303000-00009"},{"key":"10.1124\/jpet.105.095109_bib7","doi-asserted-by":"crossref","unstructured":"Bruins Slot LA, Pauwels PJ, and Colpaert FC (2002) Sign-reversal during persistent activation in \u03bc opioid signal transduction. J Theor Biol 215: 169-182.","DOI":"10.1006\/jtbi.2001.2509"},{"key":"10.1124\/jpet.105.095109_bib8","doi-asserted-by":"crossref","unstructured":"Buritova J, Tarayre JP, Besson J-M, and Colpaert FC (2003) The novel analgesic and high-efficacy 5-HT1A receptor agonist, F 13640 induces c-Fos protein expression in spinal cord dorsal horn neurons. Brain Res 974: 212-221.","DOI":"10.1016\/S0006-8993(03)02582-4"},{"key":"10.1124\/jpet.105.095109_bib9","doi-asserted-by":"crossref","unstructured":"Caill\u00e9 S, Espejo EF, R\u00e9neric JP, Cador M, Koob GF, and Stinus L (1999) Total lesion of noradrenergic neurons of the locus coeruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal and does not alter the protective properties of clonidine on opiate withdrawal. J Pharmacol Exp Ther 290: 881-892.","DOI":"10.1016\/S0022-3565(24)34977-8"},{"key":"10.1124\/jpet.105.095109_bib10","doi-asserted-by":"crossref","unstructured":"Cheng LL, Wang SJ, and Gean PW (1998) Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur J Neurosci 10: 2163-2172.","DOI":"10.1046\/j.1460-9568.1998.00229.x"},{"key":"10.1124\/jpet.105.095109_bib11","doi-asserted-by":"crossref","unstructured":"Chakrabarti S, Regec A, and Gintzler AR (2005) Chronic morphine acts via a protein kinase C\u03b3-G\u03b2-adenylyl cyclase complex to augment phosphorylation of G and G stimulatory adenylyl cyclase signaling. Mol Brain Res 138: 94-103.","DOI":"10.1016\/j.molbrainres.2005.04.004"},{"key":"10.1124\/jpet.105.095109_bib12","doi-asserted-by":"crossref","unstructured":"Colpaert FC (1996) System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 48: 355-402.","DOI":"10.1016\/S0031-6997(25)06946-7"},{"key":"10.1124\/jpet.105.095109_bib13","doi-asserted-by":"crossref","unstructured":"Colpaert FC, Meert T, De Witte P, and Schmitt P (1982) Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sci 31: 67-75.","DOI":"10.1016\/0024-3205(82)90402-7"},{"key":"10.1124\/jpet.105.095109_bib14","doi-asserted-by":"crossref","unstructured":"Colpaert FC, Tarayre JP, Alliaga M, Bruins Slot LA, Attal N, and Koek W (2001) Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats. Pain 91: 33-45.","DOI":"10.1016\/S0304-3959(00)00413-9"},{"key":"10.1124\/jpet.105.095109_bib15","doi-asserted-by":"crossref","unstructured":"Colpaert FC, Tarayre JP, Koek W, Pauwels PJ, Bardin L, Xu XJ, Wiesenfeld-Hallin Z, Cosi C, Carilla-Durand E, Assi\u00e9 MB, et al. (2002) Large-amplitude 5-HT1A receptor activation: a new mechanism of profound central analgesia. Neuropharmacology 43: 945-958.","DOI":"10.1016\/S0028-3908(02)00119-3"},{"key":"10.1124\/jpet.105.095109_bib16","doi-asserted-by":"crossref","unstructured":"Craig AD (2003) A new view of pain as a homeostatic emotion. Trends Neurosci 26: 303-307.","DOI":"10.1016\/S0166-2236(03)00123-1"},{"key":"10.1124\/jpet.105.095109_bib17","doi-asserted-by":"crossref","unstructured":"Deseure K, Koek W, Adriaensen H, and Colpaert FC (2003) Continuous administration of the 5-hydroxytryptamine1A agonist (3-chloro-4-fluoro-phenyl)-[4-fluoro-4- {[(5-methyl-pyridin-2-tmethyl)-amino]-methyl}piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain. J Pharmacol Exp Ther 306: 505-514.","DOI":"10.1124\/jpet.103.050286"},{"key":"10.1124\/jpet.105.095109_bib18","doi-asserted-by":"crossref","unstructured":"Frenois F, Cador M, Caill\u00e9 S, Stinus L, and Le Moine C (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.","DOI":"10.1046\/j.1460-9568.2002.02187.x"},{"key":"10.1124\/jpet.105.095109_bib19","doi-asserted-by":"crossref","unstructured":"Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, and Chauvin M (2000) Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93: 409-417.","DOI":"10.1097\/00000542-200008000-00019"},{"key":"10.1124\/jpet.105.095109_bib20","doi-asserted-by":"crossref","unstructured":"Hensler JG (2003) Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 72: 1665-1682.","DOI":"10.1016\/S0024-3205(02)02482-7"},{"key":"10.1124\/jpet.105.095109_bib21","doi-asserted-by":"crossref","unstructured":"Hirakawa N, Tershner SA, Fields HL, and Manning BH (2000) Bi-directional changes in affective state elicited by manipulation of medullary pain-modulatory circuitry. Neuroscience 100: 861-871.","DOI":"10.1016\/S0306-4522(00)00329-8"},{"key":"10.1124\/jpet.105.095109_bib22","doi-asserted-by":"crossref","unstructured":"Hunt SP and Mantyh PW (2001) The molecular dynamics of pain control. Nat Rev Neurosci 2: 83-91.","DOI":"10.1038\/35053509"},{"key":"10.1124\/jpet.105.095109_bib23","doi-asserted-by":"crossref","unstructured":"Hutcheson DM, Everitt BJ, Robbins TW, and Dickinson A (2001) The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 4: 943-947.","DOI":"10.1038\/nn0901-943"},{"key":"10.1124\/jpet.105.095109_bib24","doi-asserted-by":"crossref","unstructured":"Jamison RN, Kauffman J, and Katz NP (2000) Characteristics of methadone maintenance patients with chronic pain J. Pain Symptom Manage 19: 53-62.","DOI":"10.1016\/S0885-3924(99)00144-X"},{"key":"10.1124\/jpet.105.095109_bib25","doi-asserted-by":"crossref","unstructured":"Ji RR, Kohno T, Moore KA, and Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26: 696-705.","DOI":"10.1016\/j.tins.2003.09.017"},{"key":"10.1124\/jpet.105.095109_bib26","doi-asserted-by":"crossref","unstructured":"Johansen JP, Fields HL, and Manning BH (2001) The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci USA 98: 8877-8882.","DOI":"10.1073\/pnas.141218998"},{"key":"10.1124\/jpet.105.095109_bib27","doi-asserted-by":"crossref","unstructured":"Koob GF and Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science (Wash DC) 278: 52-58.","DOI":"10.1126\/science.278.5335.52"},{"key":"10.1124\/jpet.105.095109_bib28","doi-asserted-by":"crossref","unstructured":"Laviolette SR, Gallegos RA, Henriksen SJ, and van der Kooy D (2004) Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral segmental area. Nat Neurosci 7: 160-169.","DOI":"10.1038\/nn1182"},{"key":"10.1124\/jpet.105.095109_bib29","doi-asserted-by":"crossref","unstructured":"Lei L-G, Zhang Y-Q, and Zhao Z-Q (2004) Pain-related aversion and Fos expression in the central nervous system in rats. Neuroreport 15: 67-71.","DOI":"10.1097\/00001756-200401190-00014"},{"key":"10.1124\/jpet.105.095109_bib30","doi-asserted-by":"crossref","unstructured":"Liang KC (1999) Pre-or post-training injection of buspirone impaired retention in the inhibitory avoidance task: involvement of amygdala 5-HT1A receptors. Eur J Neurosci 11: 1491-1500.","DOI":"10.1046\/j.1460-9568.1999.00561.x"},{"key":"10.1124\/jpet.105.095109_bib31","doi-asserted-by":"crossref","unstructured":"Luginb\u00fchl M, Gerber A, Schnider T, Petersen-Felix S, Arendt-Nielsen L, and Curatolo M (2003) Modulation of remifentanil-induced analgesia, hyperalgesia and tolerance by small-dose ketamine in humans. Anesth Analg 96: 726-732.","DOI":"10.1213\/01.ANE.0000048086.58161.18"},{"key":"10.1124\/jpet.105.095109_bib32","doi-asserted-by":"crossref","unstructured":"Malcangio M and Lessmann V (2003) A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol Sci 24: 116-121.","DOI":"10.1016\/S0165-6147(03)00025-7"},{"key":"10.1124\/jpet.105.095109_bib33","doi-asserted-by":"crossref","unstructured":"Mao J (2002) Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100: 213-217.","DOI":"10.1016\/S0304-3959(02)00422-0"},{"key":"10.1124\/jpet.105.095109_bib34","doi-asserted-by":"crossref","unstructured":"Mueller D, Perdikaris D, and Steward J (2002) Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res 136: 389-397.","DOI":"10.1016\/S0166-4328(02)00297-8"},{"key":"10.1124\/jpet.105.095109_bib35","doi-asserted-by":"crossref","unstructured":"Ossipov MH, Lai J, Vanderah TW, and Porreca F (2003) Induction of pain facilitation by sustained opioid exposure: relationship to opioid nociceptive tolerance. Life Sci 73: 783-800.","DOI":"10.1016\/S0024-3205(03)00410-7"},{"key":"10.1124\/jpet.105.095109_bib36","doi-asserted-by":"crossref","unstructured":"Parker LA, Cyr JA, Santi A, and Burton PD (2002) The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine. Evaluation by taste and place conditioning. Pharmacol Biochem Behav 72: 87-92.","DOI":"10.1016\/S0091-3057(01)00724-9"},{"key":"10.1124\/jpet.105.095109_bib37","doi-asserted-by":"crossref","unstructured":"Pollandt S, Drephal C, and Albrecht D (2003) 8-OH-DPAT suppresses the induction of LTP in brain slices of the rat lateral amygdala. Neuroreport 14: 895-897.","DOI":"10.1097\/00001756-200305060-00025"},{"key":"10.1124\/jpet.105.095109_bib38","doi-asserted-by":"crossref","unstructured":"Richardson MP, Strange BA, and Dolan RJ (2004) Encoding of emotional memories depends on amygdala and hippocampus and their interactions. Nat Neurosci 7: 278-285.","DOI":"10.1038\/nn1190"},{"key":"10.1124\/jpet.105.095109_bib39","doi-asserted-by":"crossref","unstructured":"Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, and Portenoy RK (2003) Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. J Am Med Assoc 289: 2370-2378.","DOI":"10.1001\/jama.289.18.2370"},{"key":"10.1124\/jpet.105.095109_bib40","doi-asserted-by":"crossref","unstructured":"Scholz J and Woolf CJ (2002) Can we conquer pain? Nat Neurosci 5: 1062-1067.","DOI":"10.1038\/nn942"},{"key":"10.1124\/jpet.105.095109_bib41","doi-asserted-by":"crossref","unstructured":"Shippenberg TS (1993) Motivational effects of opioids, in Opioids II (Herz A ed) pp 633-650, Springer-Verlag, Berlin, Germany.","DOI":"10.1007\/978-3-642-77540-6_26"},{"key":"10.1124\/jpet.105.095109_bib42","doi-asserted-by":"crossref","unstructured":"Sokolowska M, Siegel S, and Kim JA (2002) Intra-administration associations: conditional hyperalgesia elicited by morphine onset cues. J Exp Psychol Anim Behav Proc 28: 309-320.","DOI":"10.1037\/\/0097-7403.28.3.309"},{"key":"10.1124\/jpet.105.095109_bib43","doi-asserted-by":"crossref","unstructured":"Varga EV, Yamamura HI, Rubenzik MK, Stropova D, Navratilova E, and Roeske WR (2003) Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment. Life Sci 74: 299-311.","DOI":"10.1016\/j.lfs.2003.09.017"},{"key":"10.1124\/jpet.105.095109_bib44","doi-asserted-by":"crossref","unstructured":"Wu WP, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Koek W, and Colpaert FC (2003) The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury. Eur J Pharmacol 478: 131-137.","DOI":"10.1016\/j.ejphar.2003.08.047"},{"key":"10.1124\/jpet.105.095109_bib45","doi-asserted-by":"crossref","unstructured":"Zacny JP, McKay MA, Toledano AY, Marks S, Young CJ, Klock AP, and Apfelbaum JL (1996) The effects of a cold-water immersion stress or on the reinforcing and subjective effects of fentanyl in healthy volunteers. Drug Alcohol Depend 42: 133-142.","DOI":"10.1016\/0376-8716(96)01274-4"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524325030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524325030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.095109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:45:58Z","timestamp":1740001558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524325030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0022356524325030"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.095109","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Efficacy 5-Hydroxytryptamine 1A Receptor Activation Counteracts Opioid Hyperallodynia and Affective Conditioning","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.095109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}